These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 2922580)

  • 1. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.
    Lindsjö M; Danielson BG; Fellström B; Ljunghall S
    Scand J Urol Nephrol; 1989; 23(1):55-9. PubMed ID: 2922580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate.
    Marangella M; Fruttero B; Bruno M; Linari F
    Clin Sci (Lond); 1982 Oct; 63(4):381-5. PubMed ID: 7105633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of increased oxalate absorption in patients with calcium-containing renal stones.
    Hodgkinson A
    Clin Sci Mol Med; 1978 Mar; 54(3):291-4. PubMed ID: 630804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers.
    Chai W; Liebman M; Kynast-Gales S; Massey L
    Am J Kidney Dis; 2004 Dec; 44(6):1060-9. PubMed ID: 15558527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease.
    Schwille PO; Hanisch E; Scholz D
    J Urol; 1984 Oct; 132(4):650-5. PubMed ID: 6471206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Okawa T
    Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [14C]Oxalate absorption by normal persons, calcium oxalate stone formers, and patients with surgically disturbed intestinal function.
    Tiselius HG; Ahlstrand C; Lundström B; Nilsson MA
    Clin Chem; 1981 Oct; 27(10):1682-5. PubMed ID: 7285319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
    Gambaro G; Petrarulo M; Nardelotto A; Marangella M; Baggio B
    Kidney Int; 1995 Nov; 48(5):1549-52. PubMed ID: 8544412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormalities in the erythrocyte membrane transport of oxalate in calcium oxalate lithogenesis].
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephrologie; 1984; 5(4):173-4. PubMed ID: 6527719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal and renal handling of oxalate loads in normal individuals and stone formers.
    Knight J; Holmes RP; Assimos DG
    Urol Res; 2007 Jun; 35(3):111-7. PubMed ID: 17431604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
    Hesse A; Schneeberger W; Engfeld S; Von Unruh GE; Sauerbruch T
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of oxalate metabolism in recurrent oxalate stone formers.
    Pinto B; Crespí G; Solé-Balcells F; Barceló P
    Kidney Int; 1974 Apr; 5(4):285-91. PubMed ID: 4853558
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
    Laminski NA; Meyers AM; Kruger M; Sonnekus MI; Margolius LP
    Br J Urol; 1991 Nov; 68(5):454-8. PubMed ID: 1747716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.